US2014030336A1PendingUtilityA1
Pharmaceutical composition for the treatment of acute disorders
Est. expirySep 24, 2018(expired)· nominal 20-yr term from priority
A61P 7/00A61P 37/00A61P 9/00A61P 43/00A61P 7/10A61P 25/20A61P 25/04A61P 3/00A61P 29/00A61P 11/00A61K 31/196A61K 31/635A61K 38/2242A61K 31/136A61K 31/445A61K 9/146A61K 31/341A61K 31/4468A61K 38/00A61K 31/4745A61K 31/4985A61K 31/34A61K 9/2866A61K 9/006A61K 31/44A61K 9/2018A61K 31/485A61K 31/5513A61K 31/19A61K 9/0056A61K 9/145A61K 9/2054A61K 36/84A61K 31/5415A61K 31/4439A61K 9/16
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical composition for the treatment or acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially water-soluble, in combination with the bioadhesion and/or mucoadhesion promoting agent. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
Claims
exact text as granted — not AI-modifiedI/we claim:
1 . A pharmaceutical composition for the treatment of acute disorders by sublingual administration, comprising an essentially water-free, ordered mixture of microparticles of at least one pharmaceutically active agent adhered to the surfaces of carrier particles, said particles being substantially larger than said microparticles and being water-soluble, and a bioadhesion and/or mucoadhesion promoting agent.
2 . A composition according to claim 1 , wherein the microparticles of said active agent or agents have a weight based mean diameter of less than 10 μm.
3 . A composition according to claim 1 , wherein the mean sieve diameter of the carrier particles is 50 to 750 μm.
4 . A composition according to claim 1 , wherein the carrier particles comprise a brittle material which will fragmentize easily when compressed.
5 . A composition according to claim 1 , wherein the carrier particles contain from 0.1 to 25 weight percent of the bio/mucoadhesion promoting agent, preferably then from 1 to 13 weight percent, based on the total composition.
6 . A composition according to claim 5 , wherein the bio/mucoadhesion promoting agent is selected from the group consisting of acrylic polymers, cellulose derivatives, natural polymers having bio/mucoadhesive properties, and mixtures thereof.
7 . A composition according to claim 6 , wherein the bio/mucoadhesion promoting agent is selected from the group consisting of cellulose derivatives and comprising hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, sodium carboxymethyl cellulose, methyl cellulose, ethyl hydroxyethyl cellulose, carboxymethyl cellulose, and modified cellulose gum; crosscaramellose; modified starch; acrylic polymers comprising carbomer and its derivatives; polyethylene oxide; chitosan; gelatin; sodium alginate; pectin; scleroglucan; xanthan gum; guar gum; poly-co(methyl vinyl ether-maleic anhydride); and mixtures thereof.
8 . A composition according to claim 1 , further comprising a pharmaceutically acceptable surfactant in a finely dispersed form and intimately mixed with the active agent or agents.
9 . A composition according to claim 8 , wherein the surfactant is present in an amount from 0.5 to 5 weight percent of the composition, preferably the 0.5 to 3 weight percent.
10 . A composition according to claim 8 , wherein the surfactant is selected from the group consisting of sodium lauryl sulfate, polysorbates, bile acid salts and mixtures thereof.
11 . A composition according to claim 1 , wherein the carrier particles comprise a water-soluble, pharmaceutically acceptable carbohydrate and/or an inorganic salt.
12 . A composition according to claim 11 , wherein the carrier particles comprise at least one of the materials mannitol, lactose, calcium phosphate and sugar.
13 . A composition according to claim 1 , wherein the carrier particles contain at least one pharmaceutical disintegrating agent promoting the dispersion of the microparticles of the active agent or agents over the sublingual mucosa.
14 . A composition according to claim 13 , wherein the disintegrating agent is selected from the group consisting of cross-linked polyvinylpyrrolidone, carboxymethyl starch, natural starch, microcrystalline cellulose, cellulose gum, and mixtures thereof.
15 . A composition according to claim 13 , wherein the disintegrating agent is present in an amount from 1 to 10 weight percent of the composition.
16 . A composition according to claim 1 , for the treatment of acute disorders by sublingual administration.
17 . A method for the treatment of acute disorders, wherein to an individual afflicted with said disorder is administered sublingually at least one dose unit of an essentially water-free pharmaceutical composition containing an effective amount of at least one pharmaceutically active agent in the form of microparticles adhered to the surfaces of carrier particles, which are substantially larger than said microparticles and are essentially water-soluble, and a bioadhesion and/or mucoadhesion promoting agent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.